Melphalan and Glipizide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Melphalan (melphalan) and Glipizide (glipizide). Common drug interactions include anaemia among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Melphalan and Glipizide. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Melphalan?

Melphalan has active ingredients of melphalan. eHealthMe is studying from 20,052 Melphalan users. Check the latest studies of Melphalan.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

On Jul, 06, 2026

22 people who take Melphalan and Glipizide together, and have interactions are studied.

Melphalan and Glipizide drug interactions.

What are the common drug interactions of Melphalan and Glipizide, by gender? *:

female:

Anaemia (lack of blood)
Back pain
Diastolic dysfunction
Dyspnoea (difficult or laboured respiration)
Gait disturbance
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haematuria (presence of blood in urine)
Mass
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteonecrosis of jaw (death of bone of jaw)

male:

Sepsis (a severe blood infection that can lead to organ failure and death)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Urine output decreased
Wound infection
Fungal infection
Hypotension (abnormally low blood pressure)
Plasma cell myeloma (cancer that begins in plasma cells)
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Seroma (a tumour like collection of serum in the tissues)
Stem cell transplant

What are the common drug interactions of Melphalan and Glipizide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Gait disturbance
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Gingivitis (inflammation of gums)
Haematuria (presence of blood in urine)
Hypokalaemia (low potassium)
Intervertebral disc degeneration (spinal disc degeneration)
Mass
Melaena (the passage of black, tarry stools)
Obesity (having too much body fat)

50-59:

n/a

60+:

Pneumonia viral
Fluid overload (too much fluid in the blood)
Abdominal abscess (collection of pus in abdomen)
Blood culture positive
Colonic obstruction (obstruction in colon)
Diverticular perforation (serious gastrointestinal condition in which the intestine's walls are perforated)
Enterococcal infection
Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
Plasma cell myeloma (cancer that begins in plasma cells)
Urine output decreased

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 19 people, 86.36%
High Blood Pressure: 8 people, 36.36%
Neuralgia (pain in one or more nerves): 6 people, 27.27%
Constipation: 6 people, 27.27%
Back Pain: 6 people, 27.27%
Abdominal Pain Upper: 6 people, 27.27%
Blood Glucose Increased: 4 people, 18.18%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 3 people, 13.64%
Pain In Extremity: 3 people, 13.64%
Ischaemic Stroke (stroke; caused by an interruption in the flow of blood to the brain): 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Melphalan and Glipizide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously